成都先导药物开发股份有限公司2025年员工持股计划第一次持有人会议决议公告

Group 1 - The first meeting of the 2025 Employee Stock Ownership Plan (ESOP) was held on January 23, 2026, with 94 participants representing 11.761442 million shares, accounting for 81.43% of the total ESOP shares of 14.443242 million [2][3] - The meeting approved the establishment of a management committee for the 2025 ESOP, which will be responsible for daily management and representing shareholders' rights [2] - The committee consists of three members, with a term aligned with the duration of the 2025 ESOP [4] Group 2 - The meeting also elected three members to the management committee: Gao Sen, Wang Zhan, and Wang Jiesi, with no conflicts of interest with major shareholders or company executives [4] - The management committee's first meeting elected Wang Jiesi as the committee chair, with a term consistent with the ESOP duration [4] - The meeting authorized the management committee to handle various matters related to the ESOP, including convening meetings, managing shares, and executing agreements [5][6]